Inovio Pharmaceuticals INO reported its Q4 earnings results on Wednesday, March 6, 2024 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Inovio Pharmaceuticals beat estimated earnings by 13.0%, reporting an EPS of $-1.1 versus an estimate of $-1.27.
Revenue was down $22 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 4.0% drop in the share price the next day.
Here's a look at Inovio Pharmaceuticals's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.56 | -1.68 | -1.68 | -2.04 |
EPS Actual | -1.56 | -1.56 | -1.92 | -2.64 |
Revenue Estimate | 120K | 260K | 270K | 340K |
Revenue Actual | 388K | 225K | 114K | 125K |
To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.